1. Introduction
Carbon monoxide (CO) poisoning is a life-threatening emergency that happens when CO binds to hemoglobin, forming carboxyhemoglobin (COHb). This process impairs the body's ability to transport and use oxygen effectively. Without timely, proper treatment, CO poisoning can result in severe neurological damage, organ failure, and even death. Hyperbaric oxygen (HBO) therapy, delivered through a hyperbaric chamber, is a well-regarded intervention for CO poisoning. It addresses the key physiological issues caused by the condition, helping to improve patient outcomes.
2. Mechanism of Action: How Hyperbaric Chambers Treat CO Poisoning
The hyperbaric chamber operates by enclosing the patient in a sealed environment where pressure is increased to 1.5–3 atmospheres absolute (ATA), and 100% pure oxygen is administered. This unique setting exerts multiple therapeutic effects targeting CO-induced toxicity:
Accelerates COHb Dissociation: Under normal atmospheric pressure (1 ATA) with 100% oxygen, the half-life of COHb is approximately 74 minutes. At 3 ATA, this half-life is reduced to just 20–25 minutes. The increased partial pressure of oxygen (PO₂) in the chamber displaces CO from hemoglobin molecules, promoting the rapid formation of oxyhemoglobin and restoring oxygen-carrying capacity.
Enhances Tissue Oxygenation: High-pressure oxygen increases the dissolved oxygen content in plasma from 0.3 mL/dL (at 1 ATA, room air) to up to 6 mL/dL (at 3 ATA). This dissolved oxygen bypasses the hemoglobin system, directly delivering oxygen to hypoxic tissues-critical for organs with high oxygen demand, such as the brain and heart, which are most vulnerable to CO poisoning.
Reduces Oxidative Stress and Inflammation: CO poisoning induces the production of reactive oxygen species (ROS) and inflammatory mediators, contributing to secondary tissue damage. HBO therapy mitigates this by stabilizing cell membranes, inhibiting neutrophil activation, and reducing the release of pro-inflammatory cytokines, thereby limiting post-toxicity injury.
Prevents Delayed Neurological Sequelae (DNS): A major complication of CO poisoning is DNS, which can occur 2–40 days after initial recovery and includes symptoms like memory loss, depression, and motor dysfunction. HBO reduces the risk of DNS by improving cerebral oxygenation, promoting neuronal repair, and inhibiting the formation of microthrombi in cerebral vasculature.
3. Types of Hyperbaric Chambers Used
Two main types of hyperbaric chambers are employed in CO poisoning treatment, each with distinct applications:
Monoplace Chambers: These chambers are designed to treat one patient at a time and are pressurized with 100% oxygen. They provide precise control over pressure, making them well-suited for critically ill patients who need continuous monitoring-such as ECG or pulse oximetry-or mechanical ventilation. Their compact size also allows for easy integration into emergency departments.
Multiplace Chambers: These larger chambers can hold multiple patients, or a patient plus medical staff. They are pressurized with air, and patients receive oxygen through masks or hoods. Multiplace chambers are useful for treating groups of patients-like in mass CO poisoning incidents-and let medical personnel provide hands-on care during therapy, such as giving medications or adjusting life support equipment.
4. Indications for HBO Therapy in CO Poisoning
HBO therapy is not universally required for all CO poisoning cases. Clinical guidelines recommend its use in the following high-risk scenarios:
COHb levels ≥25% (or ≥15% in pregnant patients, as CO crosses the placenta and endangers the fetus).
Neurological symptoms (e.g., confusion, seizures, loss of consciousness, focal deficits) regardless of COHb level.
Cardiovascular involvement (e.g., chest pain, arrhythmias, myocardial ischemia).
Pregnancy (due to the fetus's increased susceptibility to CO-induced hypoxia).
Delayed onset of symptoms or a history of prolonged CO exposure.
Failure to improve with normobaric oxygen (NBO) therapy (administering 100% oxygen at 1 ATA).
For mild cases (e.g., COHb <15% with no symptoms), NBO may be sufficient, but close monitoring for symptom progression is essential.
5. Treatment Protocol and Course
The HBO treatment protocol for CO poisoning is standardized but may be adjusted based on patient severity:
Pre-Therapy Preparation: Patients undergo initial stabilization, including airway management, fluid resuscitation, and NBO administration while being transported to the hyperbaric facility. Contraindications (e.g., untreated pneumothorax, middle ear infection) are ruled out via clinical exam and imaging.
Therapy Session: The chamber is pressurized gradually (to avoid barotrauma) to the target pressure (typically 2–3 ATA). Patients breathe 100% oxygen for 90–120 minutes, with intermittent "air breaks" (5–10 minutes of breathing air) in some protocols to reduce the risk of oxygen toxicity.
Decompression: Pressure is reduced slowly to prevent decompression sickness (the formation of nitrogen bubbles in the bloodstream). This phase is critical for patient safety and may take 20–30 minutes.
Number of Sessions: Most patients require 1–3 sessions. However, those with severe neurological damage or DNS may need additional treatments (up to 10–20 sessions) to optimize recovery.
6. Safety Considerations and Potential Complications
HBO therapy is generally safe when administered by trained personnel, but it carries potential risks that require careful management:
Barotrauma: Damage to the middle ear, sinuses, or lungs due to pressure changes. Prevented by teaching patients to equalize pressure (e.g., swallowing, Valsalva maneuver) and monitoring for respiratory distress.
Oxygen Toxicity: Can manifest as convulsions (CNS toxicity) or pulmonary edema (pulmonary toxicity). Mitigated by adhering to recommended pressure and duration limits and using air breaks.
Decompression Sickness: Rare in CO poisoning protocols but possible if decompression is too rapid. Treated with re-pressurization in the chamber.
Fire Hazard: 100% oxygen is highly flammable. Strict safety protocols are enforced, including removing all ignition sources (e.g., lighters, electronic devices) and using fire-resistant materials in the chamber.
7. Prognostic Benefits
Many studies have shown that HBO therapy often delivers better results than normobaric oxygen (NBO) for CO poisoning. Notable benefits related to patient outcomes include:
Faster resolution of symptoms (e.g., headache, dizziness, confusion).
A notable reduction in the risk of Delayed Neurological Sequelae (DNS), with studies indicating lower risk-often by half or more-in high-risk patients.
Improved long-term neurological outcomes, including better cognitive function and quality of life.
Reduced mortality in severe cases, particularly those with cardiovascular or cerebral involvement.
8. Latest Clinical Research Progress
In recent years, with the advancement of medical technology, clinical research on hyperbaric oxygen therapy for carbon monoxide poisoning has continued to deepen, bringing new insights into treatment optimization and efficacy evaluation:
Personalized Treatment Based on Biomarkers: Emerging studies focus on using biomarkers such as neuron-specific enolase (NSE) and S100β protein to assess the severity of cerebral injury in CO poisoning patients. By combining these biomarkers with clinical manifestations, doctors can develop more personalized HBO treatment plans-for example, increasing the number of treatment sessions for patients with significantly elevated NSE levels to improve neurological prognosis.
Combination Therapy with Neuroprotective Agents: Research has shown that combining HBO therapy with neuroprotective agents (e.g., edaravone, which scavenges free radicals, and citicoline, which promotes nerve cell metabolism) can produce a synergistic effect. This combination not only enhances the oxygen supply to damaged brain tissue but also directly inhibits neuronal apoptosis, further reducing the risk of delayed neurological sequelae.
Application of Portable Hyperbaric Chambers in Emergency Scenarios: The development of lightweight, portable hyperbaric chambers has expanded the application of HBO therapy in pre-hospital emergency care. In remote areas or on-site accident scenes, emergency personnel can use these chambers to initiate preliminary HBO treatment immediately, shortening the time from poisoning to effective oxygen intervention and improving the survival rate of critically ill patients.
Long-Term Outcome Follow-Up Studies: A 5-year follow-up study of CO poisoning patients treated with HBO found that compared with those receiving only normobaric oxygen therapy, the HBO group had a 32% lower incidence of chronic cognitive impairment and a 28% higher quality of life score. This confirms the long-term beneficial effects of HBO therapy on neurological function.
9. Conclusion
Hyperbaric chamber therapy is a vital and evidence-based intervention for carbon monoxide poisoning, targeting the root cause of toxicity by enhancing oxygen delivery and accelerating CO elimination. Its ability to reduce delayed neurological sequelae and improve survival makes it indispensable in the management of high-risk CO poisoning cases. With the integration of personalized biomarker-guided treatment, combination therapy with neuroprotective agents, and the popularization of portable equipment, the efficacy and accessibility of HBO therapy are continuously improving. While safe when performed by experienced teams, careful patient selection, adherence to protocols, and strict safety measures are essential to maximize its benefits. As emergency care continues to advance, the role of hyperbaric oxygen therapy remains central to optimizing outcomes for patients with CO poisoning.
Hyperbaric chamber therapy is a valuable, evidence-supported intervention for carbon monoxide poisoning. It targets the root cause of CO toxicity by boosting oxygen delivery and speeding up CO elimination from the body. One of its key strengths is its potential to reduce the risk of delayed neurological sequelae and support better survival rates, making it an important part of caring for high-risk CO poisoning patients. When administered by trained teams, HBO therapy is generally safe-but careful patient selection, adherence to established protocols, and strict safety measures are all crucial to ensuring the best possible results. As emergency care practices continue to evolve, hyperbaric oxygen therapy remains a central component in helping optimize outcomes for those affected by CO poisoning.